Profile picture

Doctor Stephanie Schwarting

Ludwig Maximilians University, Munich (Germany)
Membership: ESC Professional Member HFA Member
Follow
Biography
Board certified cardiologist with expertise in cardiac infiltrative disease (amyloidosis) and cardiovascular imaging (echocardiography & CMR). Member of International Society of Amyloidosis, Cardiac Transthyretin Amyloidosis Fellowship of ISA 2023/2024. Research areas: ATTR-Cardiomyopathy, echocardiography
Logo ESC

Contributor content

3x illustrative case reports (5' each) - 1 DCM , 1 HCM and 1 amyloid
Presentation
3x illustrative case reports (5' each) - 1 DCM , 1 HCM and 1 amyloid
Assessing dual pathology in aortic stenosis: Likelihood scores for transthyretin amyloid cardiomyopathy in patients of different aortic stenosis flow groups undergoing TAVI.
Presentation
Assessing dual pathology in aortic stenosis: Likelihood scores for transthyretin amyloid cardiomyopathy in patients of different aortic stenosis flow groups undergoing TAVI.
Impaired right ventricular free wall strain predicts mortality in patients with stabilizer-treated transthyretin amyloid cardiomyopathy.
Presentation
Impaired right ventricular free wall strain predicts mortality in patients with stabilizer-treated transthyretin amyloid cardiomyopathy.
RV-PA uncoupling is a strong predictor of 3-year all-cause mortality in transthyretin amyloid cardiomyopathy.
Presentation
RV-PA uncoupling is a strong predictor of 3-year all-cause mortality in transthyretin amyloid cardiomyopathy.

ESC 365 is supported by